Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese patients with type 2 diabetes

Diabetes Care

Volumn 21, Issue 1, 1998, Pages 9-15

  Gumbiner, Barry ^a   Low, Cecilia C ^b   Reaven, Peter D ^c  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MONOUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARBOHYDRATE INTAKE; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; FAT INTAKE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOPROTEIN METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK FACTOR; WEIGHT REDUCTION;

EID: 0031964834     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.1.9     Document Type: Article

References (42)

1. Savage PJ: Cardiovascular complications of diabetes mellitus: what we know and what we need to know about their prevention. Ann Intern Med 124:123-126, 1996
2. American Diabetes Association: Detection and management of lipid disorders in diabetes (Consensus Statement). Diabetes Care 18 (Suppl. 1):86-93, 1995
3. Reaven PD: Mechanisms of atherosclerosis: role of LDL oxidation. Adv Exp Med Bio 336:113-128, 1994
4. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924, 1989
5. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ: Atherosclerosis: basic mechanisms oxidation, inflammation, and genetics. Circulation 91:2488-2496, 1995
6. Chisolm GM: Oxidized lipoproteins and leukocyte-endothelial interactions: growing evidence for multiple mechanisms. Lab Invest 68:369-371, 1993
7. Reaven PD, Witztum JL: The role of oxidation of LDL in atherogenesis. Endocrinology 5:44-54, 1995
8. Reaven P: Dietary and pharmacologic regimens to reduce lipid peroxidation in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 62:14835-14895, 1995
9. Hendriks JCM, Stalenoef AFH, deGraaf J, Hak-Lemmers HLM, Hectors MC, Demacker PNM: Enhanced susceptibility to in vitro oxidation of the dense low-density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 11:298-306, 1991
10. Tribble DL, Holl LG, Wood PD, Krauss RM: Variations in oxidative susceptibility among six low-density lipoprotein subtractions of differing density and particle size. Atherosclerosis 93:189-199, 1992
11. Reaven PD, Herold DA, Barnett J, Edelman S: Effects of vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care 18:807-816, 1995
12. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM: LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb 12:1496-1502, 1992
13. Havel R: Triglyceride-rich lipoproteins and atherosclerosis: new perspectives. Am J Clin Nutr 59:795-796, 1994
14. Coulston AM, Hollenbeck CB, Swislocki ALM, Chen Y-DI, Reaven GM: Deleterious metabolic effects of high-carbohydrate, sucrose-containing diets in patients with non-insulin-dependent diabetes mellitus. Am J Med 82:213-220, 1987
15. Garg A, Bonanome A, Grundy SM, Zhang Z, Unger RH: Comparison of a high-carbohydrate diet with a high-monounsaturated fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 319:829-834, 1988
16. Garg A, Bantle JP, Henry RR, Coulston AM, Griver KA, Raatz SK, Brinkley L, Chen I, Grundy SM, Huet BA, Reaven GM: Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. JAMA 271:1421-1428, 1994
17. Rasmussen OW, Thomsen C, Hansen KW, Vesterlund M, Winther E, Hermansen K: Effects on blood pressure, glucose, and lipid levels of a high-monounsaturated fat diet compared with a high-carbohydrate diet in NIDDM subjects. Diabetes Care 16:1565-1571, 1993
18. Abbot W, Boyce V, Grundy S, Howard B: Effects of replacing saturated fat with complex carbohydrate in diets of subjects with NIDDM. Diabetes Care 12:102-107, 1989
19. Howard BV, Abbott WGH, Swinburn BA: Evaluation of metabolic effects of substitution of complex carbohydrates for saturated fat in individuals with obesity and NIDDM. Diabetes Care 14:786-795, 1991
20. Henry RR, Scheaffer L, Olefsky JM: Glycemic effects of intensive caloric restriction and isocaloric refeeding in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 61:917-925, 1985
21. Kasim SE, Darga LL, Holden JH, Khilnani S, Patton S, Catherine Jen KL, Lucas CP: Relationships between the amount of weight loss and post-heparin lipoprotein lipase activity in patients with type II diabetes. Int J Obes 15:833-840, 1991
22. Henry RR, Gumbiner B: Benefits and limitations of very-low-calorie diet therapy in obese NIDDM. Diabetes Care 14:802-823, 1991
23. Franz M: How enthusiastically should the use of monounsaturated fats be encouraged? Diabetes Educ 15:494-497, 1994
24. Low CC, Grossman EB, Gumbiner B: Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients. Diabetes 45:569-571, 1996
25. Welle S, Forbes GB, Statt M, Barnard R, Amatruda JM: Energy expenditure under free-living conditions in normal-weight and overweight women. Am J Clin Nutr 55:14-21, 1992
26. Gould KL, Ornish D, Kirkeeide R, Brown S, Stuart Y, Buchi M, Billings J, Armstrong W, Ports T, Scherwitz L: Improved stenosis geometry by quantitative coronary arteriography after vigorous risk factor modification. Am J Cardiol 69:845-853, 1992
27. Kleinveld HA, Hal-Lemmers AF, Stalenhoef PN: Improved measurement of low-density lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin Chem 38:2066-2072, 1992
28. Rumsey SC, Galeano NF, Arad Y, Deckelbaum RJ: Cyropreservation with sucrose maintains normal physical and biological properties of human plasma low-density lipoproteins. J Lipid Res 33:1551-1561, 1992
29. Rumsey SC, Stucchi AF, Nicolosi RJ, Ginsberg HN, Ramakrishnan R, Deckelbaum RJ: Cyropreserved with sucrose maintains in vivo kinetics indistinguishable from freshly isolated human LDL in cynomolgus monkeys. J Lipid Res 35:1592-1598, 1994
30. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
31. Reaven P, Parthasarathy S, Grasse B, Miller E, Almazan F, Mattson R, Khoo J, Steinberg D, Witztum J: Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein of oxidative modification in humans. Am J Clin Nutr 54:710-706, 1991
32. Esterbauer H, Striegl G, Puhl H, Rotheneder M: Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Free Radical Res Commun 6:67-75, 1989
33. Fisler JS, Drenick EJ: Starvation and semistarvation diets in the management of obesity. Annu Rev Nutr 7:465-484, 1987
34. National Cholesterol Education Program Expert Panel: Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 148:36-69, 1988
35. NIH Consensus Development Panel on Triglyceride HL: Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 269:505-510, 1993
36. Tracy RE, Newmann WP, Wattigney WA, Berenson GS: Risk factors and atherosclerosis in youth autopsy findings of the Bogalusa Heart Study. Am J Med Sci 310:S37-541, 1995
37. Tornvall P, Bavenholm P, Landou C, de Faire U, Hamsten A: Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Circulation 88:2180-2189, 1993
38. Garg A: Insulin resistance in the pathogenesis of dyslipidemia. Diabetes Care 19:387-389, 1996
39. Fuller CJ, Chandalia M, Garg A, Grundy SM, Jialal I: RRR-α-tocopheryl acetate supplementation at pharmacologic doses decreases low-density lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus. Am J Clin Nutr 63:753-759, 1996
40. Princen HMG, van Duyvenvoorde W, Buytenhek R, van der Laarse A, van Poppel G, Gevers Leuven JA, van Hinsbergh VWM: Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol 15:325-333, 1995
41. Jialal I, Fuller CJ, Huet BA: The effect of alpha-tocopherol supplementation on LDL oxidation: a dose-response study. Arterioscler Thromb Vasc Biol 15:190-198, 1995
42. Reaven PD, Grasse BJ, Tribble DL: Effects of linoleate-rich and oleate-rich diets in combination with α-tocopherol on the susceptibility of low-density lipoproteins (LDL) and LDL subfractions to oxidative modification in humans. Arterioscler Thromb 14:557-566, 1993